There is a shortage of an important medical product in the occupied Crimea

In the temporarily occupied Crimea and several regions of the Russian Federation, there have been interruptions in the supply of anti-rhesus immunoglobulin, which is vital for pregnant women with a negative Rh factor.

This is reported by the website Krym.Realii.

The report says that problems with the availability of this drug, in addition to Crimea, are also observed in St. Petersburg, Yaroslavl and Penza regions, and the Krasnoyarsk Territory of the Russian Federation. The drug is also not available in large online pharmacies in Russia, such as Eaptek, Asna, and Zdravsity. The Ministry of Health of the Penza region of the Russian Federation confirmed that rhesus immunization is currently temporarily impossible due to a shortage of medicines (anti-rhesus immunoglobulin and its analogues).

Anti-rhesus immunoglobulin is a vital medicine and is required for women with a negative Rh factor from the 28th week of pregnancy. There are four drugs on the Russian market, three of which are imported. The share of the Russian drug produced by the Ivanovo Regional Blood Transfusion Station is only 4.3% of the market. For many years, the need for anti-rheumatic immunoglobulin in Russia has been covered by imported drugs. However, in 2024, the cost of the drug increased due to a global plasma shortage. This drug is included in the list of vital drugs, which limits the possibility of raising its price and makes supplies to Russia unprofitable for manufacturers.

The post added that Roszdravnadzor told reporters that the country now has 46,000 packs of anti-rhesus immunoglobulin and another 90,000 packs are expected to be delivered by the end of the year. In August, the media reported that in the first half of 2024, the Russian market received about 48 thousand packages of anti-mumps immunoglobulin, which is 71% less than in the same period last year.

There is a shortage of an important medical product in the occupied Crimea

You might also like: